Tralokinumab 300 mg

BIOLOGICAL2 trials

Sponsors

MedImmune LLC

Conditions

AsthmaHealthy Subjects or Volunteers

Phase 1

A Phase 1, Open-label Study to Investigate the Pharmacokinetics of Tralokinumab (CAT-354) in Adolescents With Asthma

CompletedNCT01592396

MedImmune LLCAsthma

Start: 2012-06-30End: 2013-01-31Updated: 2017-03-06

A Study of Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy Volunteers

CompletedNCT02085473

MedImmune LLCAsthma, Healthy Subjects or Volunteers

Start: 2014-03-19End: 2014-07-10Updated: 2018-12-31